BRAF and lung carcinoma: Lung cancer adenocarcinomas are predominantly associated with the following: Kirsten rat sarcoma viral oncogene homolog (KRAS - 32%); epidermal grow factor receptor (11%), and V-Raf murine sarcoma viral oncogene homolog B (BRAF - 7%) driver mutations.